FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1522152077> ?p ?o ?g. }

• W1522152077 endingPage "E257" @default.
• W1522152077 startingPage "E250" @default.
• W1522152077 abstract "•To conduct a retrospective, multicentre, cohort analysis to assess the sequential use of the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib.•Records of 189 patients with renal-cell carcinoma (RCC) who were treated with sorafenib and sunitinib sequentially between March 2004 and April 2009 at 12 Italian study centres were analysed. •Patients were treated under European Expanded Access Programmes or, following market approval, in general clinical practice. •Interventions were sorafenib (800 mg/day) and sunitinib (50 mg every day; 4 weeks on and 2 weeks off). •Progression-free survival (PFS) during treatment with the first and second TKI was evaluated.•In all, 99 patients were treated with sunitinib followed by sorafenib (SuSo) and 90 were treated with sorafenib followed by sunitinib (SoSu); 104 (55%) patients had received prior systemic therapy, mostly with cytokines. •The median (range) PFS on the first TKI was similar between treatment groups [sorafenib 8.4 (1.1-28.9) months; sunitinib 7.8 (0.5-30.4) months; hazard ratio (HR) 1.05, 95% confidence interval (CI) 0.78-1.40, P=0.758]. Multivariate analysis showed that good Memorial Sloan-Kettering Cancer Center status was associated with increased PFS. •After the second TKI, patients in the SoSu group had a longer median PFS than those in the SuSo group (7.9 months vs 4.2 months, respectively; HR 0.54, 95% CI 0.39-0.74, P<0.001). •Multivariate analysis showed only treatment and Eastern Cooperative Oncology Group performance status (and not age, gender, study centre or previous treatment) were significantly associated with duration of PFS.•Our findings suggest a limited cross-resistance between sorafenib and sunitinib and that the sequence SoSu may result in a longer combined PFS than SuSo. This is the largest retrospective study to date, though its findings are limited in part by the retrospective nature." @default.
• W1522152077 created "2016-06-24" @default.
• W1522152077 creator A5005319110 @default.
• W1522152077 creator A5026639715 @default.
• W1522152077 creator A5030122361 @default.
• W1522152077 creator A5031898133 @default.
• W1522152077 creator A5044527837 @default.
• W1522152077 creator A5045603955 @default.
• W1522152077 creator A5048564367 @default.
• W1522152077 creator A5053179795 @default.
• W1522152077 creator A5057926104 @default.
• W1522152077 creator A5060970119 @default.
• W1522152077 creator A5062273587 @default.
• W1522152077 creator A5063424146 @default.
• W1522152077 creator A5065611917 @default.
• W1522152077 creator A5070704228 @default.
• W1522152077 creator A5071233660 @default.
• W1522152077 creator A5073892178 @default.
• W1522152077 creator A5085869739 @default.
• W1522152077 creator A5090509109 @default.
• W1522152077 date "2011-05-23" @default.
• W1522152077 modified "2023-10-02" @default.
• W1522152077 title "Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases" @default.
• W1522152077 cites W1520255941 @default.
• W1522152077 cites W1970600886 @default.
• W1522152077 cites W1978732845 @default.
• W1522152077 cites W2005831962 @default.
• W1522152077 cites W2028525468 @default.
• W1522152077 cites W2070019048 @default.
• W1522152077 cites W2078449820 @default.
• W1522152077 cites W2092100683 @default.
• W1522152077 cites W2099088585 @default.
• W1522152077 cites W2100669312 @default.
• W1522152077 cites W2105677187 @default.
• W1522152077 cites W2110720470 @default.
• W1522152077 cites W2115793908 @default.
• W1522152077 cites W2118677643 @default.
• W1522152077 cites W2139248078 @default.
• W1522152077 cites W2140088548 @default.
• W1522152077 cites W2142297664 @default.
• W1522152077 cites W2149026055 @default.
• W1522152077 cites W2153867442 @default.
• W1522152077 cites W2156408558 @default.
• W1522152077 cites W2157262448 @default.
• W1522152077 cites W2162225483 @default.
• W1522152077 cites W2166788033 @default.
• W1522152077 cites W2170339563 @default.
• W1522152077 cites W2241079867 @default.
• W1522152077 cites W2247162636 @default.
• W1522152077 cites W4254757623 @default.
• W1522152077 doi "https://doi.org/10.1111/j.1464-410x.2011.10186.x" @default.
• W1522152077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21599821" @default.
• W1522152077 hasPublicationYear "2011" @default.
• W1522152077 type Work @default.
• W1522152077 sameAs 1522152077 @default.
• W1522152077 citedByCount "77" @default.
• W1522152077 countsByYear W15221520772012 @default.
• W1522152077 countsByYear W15221520772013 @default.
• W1522152077 countsByYear W15221520772014 @default.
• W1522152077 countsByYear W15221520772015 @default.
• W1522152077 countsByYear W15221520772016 @default.
• W1522152077 countsByYear W15221520772017 @default.
• W1522152077 countsByYear W15221520772018 @default.
• W1522152077 countsByYear W15221520772019 @default.
• W1522152077 countsByYear W15221520772021 @default.
• W1522152077 countsByYear W15221520772023 @default.
• W1522152077 crossrefType "journal-article" @default.
• W1522152077 hasAuthorship W1522152077A5005319110 @default.
• W1522152077 hasAuthorship W1522152077A5026639715 @default.
• W1522152077 hasAuthorship W1522152077A5030122361 @default.
• W1522152077 hasAuthorship W1522152077A5031898133 @default.
• W1522152077 hasAuthorship W1522152077A5044527837 @default.
• W1522152077 hasAuthorship W1522152077A5045603955 @default.
• W1522152077 hasAuthorship W1522152077A5048564367 @default.
• W1522152077 hasAuthorship W1522152077A5053179795 @default.
• W1522152077 hasAuthorship W1522152077A5057926104 @default.
• W1522152077 hasAuthorship W1522152077A5060970119 @default.
• W1522152077 hasAuthorship W1522152077A5062273587 @default.
• W1522152077 hasAuthorship W1522152077A5063424146 @default.
• W1522152077 hasAuthorship W1522152077A5065611917 @default.
• W1522152077 hasAuthorship W1522152077A5070704228 @default.
• W1522152077 hasAuthorship W1522152077A5071233660 @default.
• W1522152077 hasAuthorship W1522152077A5073892178 @default.
• W1522152077 hasAuthorship W1522152077A5085869739 @default.
• W1522152077 hasAuthorship W1522152077A5090509109 @default.
• W1522152077 hasBestOaLocation W15221520771 @default.
• W1522152077 hasConcept C121608353 @default.
• W1522152077 hasConcept C126322002 @default.
• W1522152077 hasConcept C141071460 @default.
• W1522152077 hasConcept C143998085 @default.
• W1522152077 hasConcept C167135981 @default.
• W1522152077 hasConcept C207103383 @default.
• W1522152077 hasConcept C2777472916 @default.
• W1522152077 hasConcept C2778019345 @default.
• W1522152077 hasConcept C2778695046 @default.
• W1522152077 hasConcept C2778820342 @default.
• W1522152077 hasConcept C2779490328 @default.
• W1522152077 hasConcept C2781068499 @default.

• next